Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gerl

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancerE W Steyerberg, A Gerl, S D Fossá, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H-G Derigs, et al.
Radiology|May 5, 2000
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapyE W Steyerberg, H J Keizer, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Cancer|January 15, 1997
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study GroupE W Steyerberg, H J Keizer, J E Messemer, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Prognostic variables for response and outcome in patients with extragonadal germ-cell tumorsJ T Hartmann, C R Nichols, J-P Droz, et al.
Cancer|March 26, 1999
Treatment outcome of patients with brain metastases from malignant germ cell tumorsS D Fosså, C Bokemeyer, A Gerl, et al.
British Journal of Cancer|July 22, 2004
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trialsC Bokemeyer, C Kollmannsberger, S Stenning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancerE W Steyerberg, A Gerl, S D Fossá, et al.
Journal of the National Cancer Institute|January 6, 2000
Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumorsJ T Hartmann, C R Nichols, J P Droz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H-G Derigs, et al.
Radiology|May 5, 2000
Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapyE W Steyerberg, H J Keizer, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysisJ T Hartmann, L Einhorn, C R Nichols, et al.
Cancer|January 15, 1997
Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study GroupE W Steyerberg, H J Keizer, J E Messemer, et al.
Cancer|April 3, 2001
Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcomeC Bokemeyer, J P Droz, A Horwich, et al.
Pageof 8